Royal Blood Announce 2027 North American Tour

Royal Blood is set to embark on a North American tour in April 2027, marking the next major phase of activity following the November 2026 release of their latest album, Dead Company. The tour will cover multiple cities across the United States and Canada, including stops in Boston, Philadelphia, Chicago, Seattle, and Los Angeles. This run is scheduled to begin on April 2, 2027, in Boston and conclude on April 22 in Los Angeles.

The tour will feature support from the band Bodega and will showcase a blend of tracks from Dead Company alongside selections from Royal Blood’s previous albums. Tickets will be available through Ticketmaster, with a pre-sale starting on November 12, 2026, at 10 a.m. local time, followed by a general public on-sale beginning November 13 at the same time.

Before crossing the Atlantic, Royal Blood plans a series of UK performances later in November 2026, including multiple shows in Kingston upon Thames and Oxford. These are followed by a European tour in February and March 2027, with concerts scheduled in major cities like Paris, Berlin, Milan, and Madrid.

The North American tour reflects the band's strategy to maintain momentum generated by Dead Company, which was released on November 6, 2026. The album’s launch just days ahead of the announced tour indicates an integrated approach to promotion, combining new music exposure with live performances to engage their fan base across continents.

Royal Blood, consisting of singer-bassist Mike Kerr and drummer Ben Thatcher, have built their reputation on high-energy performances and a distinctive raw sound. The decision to include both new songs and established hits in their setlist suggests an intention to balance fan expectations with showcasing their evolving artistry.

This tour also highlights the band's continued relevance in the rock genre, a sector known for fluctuating commercial success. By scheduling extensive live dates across North America after their UK and European runs, Royal Blood is reinforcing their international appeal and commitment to touring as a primary driver of their career.

The choice of venues, such as The Belasco in Los Angeles and Union Transfer in Philadelphia, points to mid-sized, prominent locations that can accommodate dedicated audiences without losing the intimacy crucial to rock concerts. This scale is consistent with the band's current status, positioned between emerging acts and stadium headliners.

The inclusion of Bodega as the supporting act adds an interesting layer to the tour’s lineup, possibly attracting diverse audiences and expanding the overall reach of the concerts. Bodega's presence may also complement Royal Blood’s sound and appeal.

Beyond the tour itself, Royal Blood's activity underscores the ongoing importance of album cycles combined with live touring in sustaining artist visibility and commercial viability in the modern music industry. Their schedule suggests a rigorous commitment to touring as a means to capitalize on the new album's release and fan engagement.

The detailed itinerary for the UK and European legs includes multiple dates in select cities, with some locations hosting both early and late shows. This approach indicates strong demand in those markets and a willingness to accommodate larger numbers of fans.

While the itinerary for North America is firmly set, further details about promotional activities, potential festival appearances, or broadcast events tied to the tour have not yet been disclosed. These elements could become clearer closer to the tour commencement.

Overall, Royal Blood’s planned 2027 touring campaign is an ambitious undertaking that follows a strategic pattern of new music release coupled with extensive live dates. Their ability to maintain relevance through consistent touring amidst a competitive rock landscape will be a key factor in the ongoing success of their career.

The band's schedule, spanning from the end of 2026 through spring 2027, also suggests a period of intense activity that may be followed by additional projects or a break, although no official plans have been announced. This tour cycle will likely define their public presence for the foreseeable future.